text: <unk> (Rebinyn) is a recombinant DNA-derived<unk>  Factor<unk>  concentrate that is FDA approved for the on-demand treatment and control of bleeding episodes and perioperative management of bleeding.   Common adverse reactions include itching and injection site reactions.
option_0: Coagulation factor IX, GlycoPEGylated 
option_1: Vitamin K
option_2: Rapid plasma reagent
option_3: Recombinant factor VIIa
option_4: Factor XIII concentrate
option_5: Thrombin human
option_6: Factor IX complex
option_7: Factor ix complex